Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy.

BMC medical genomics - 17 Mar 2021

Tian Yong, Wang Junhong, Liu Yanxiao, Luo Xiangguang, Yao Ziying, Wang Xinjun, Zhang Yuanyuan, Xu Cheng, Zhao Xiaoyu

Abstract excerpt

BACKGROUND: To determine the clinical value of multigene polymorphisms, LDL-C and sdLDL-C on T2DM therapy. METHODS: In total, 352 T2DM patients before and after treatment and 48 healthy individuals were enrolled in this study. LDL-C and sdLDL-C were detected in 352 T2DM patients and 48 healthy individuals by Quantimetrix Lipoprint System. The 11 gene polymorphisms-HTR3B (rs2276307, A > G), APOE (rs7412,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged
Share to Case-Control Studies
Share to Cholesterol, LDL
Share to Diabetes Mellitus, Type 2
Share to Genetic Testing
Share to Polymorphism, Single Nucleotide
Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 33731122
DOI: 10.1186/s12920-021-00937-8
PMCID: PMC7972339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapy.PMID 33731122Read ↗

MassARRAY multigene screening combined with LDL-C and sdLDL-C detection for more favorable outcomes in type 2 diabetes mellitus therapySemantic proximity Read ↗

Genetic Polymorphisms, LDL-C and sdLDL-C Help Optimize Coronary Heart Disease (CHD) TherapySemantic proximity Read ↗

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.Semantic proximity Read ↗

National Lipid Association Annual Summary of Clinical Lipidology 2015.Semantic proximity Read ↗

Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.Semantic proximity Read ↗

Evidence of association between single-nucleotide polymorphisms in lipid metabolism-related genes and type 2 diabetes mellitus in a Chinese population.Semantic proximity Read ↗

Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies.Semantic proximity Read ↗

Epigenetic Link Between Statin Therapy and Type 2 Diabetes.Semantic proximity Read ↗

Genetic association of lipids and lipid-lowering drug targets with the risk of type 1 diabetes and its complicationsSemantic proximity Read ↗

Identification of the biomarkers of ACS co-morbid T2DM in human serum through UHPLC/MS studySemantic proximity Read ↗

HMGCR genetic variation and risk of new-onset type 2 diabetes in statin users.Semantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.